CAPA, which stands for Corrective and Preventive Action, is a systematic approach used in clinical research and other regulated industries to address and resolve quality issues. It involves identifying the root cause of a problem, implementing corrective measures to fix the immediate issue, and taking preventive steps to ensure the problem does not recur in the future.
The CAPA process is an essential component of quality management systems and is often required by regulatory agencies such as the FDA. It helps organizations maintain compliance, improve processes, and enhance overall quality by addressing both existing problems and potential risks proactively.
CAPA is crucial in clinical research as it ensures the integrity and reliability of study data and processes. By systematically addressing issues and preventing their recurrence, CAPA helps maintain compliance with Good Clinical Practice (GCP) guidelines and regulatory requirements, which is essential for the validity of clinical trials.
Furthermore, CAPA contributes to continuous improvement in clinical research operations. It promotes a culture of quality and accountability, leading to more efficient processes, reduced errors, and ultimately, safer and more effective clinical trials that can benefit patients and advance medical knowledge.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant